エーザイ：BIOGEN’S DISCLOSURE ABOUT THE SUBMISSION OF MARKETING AUTHORIZATION APPLICATION TO EUROPEAN MEDICINES AGENCY FOR ADUCANUMAB FOR ALZHEIMER’S DISEASE - 有報キャッチャー

エーザイ（4523）　BIOGEN’S DISCLOSURE ABOUT THE SUBMISSION OF MARKETING AUTHORIZATION APPLICATION TO EUROPEAN MEDICINES AGENCY FOR ADUCANUMAB FOR ALZHEIMER’S DISEASE 2020/10/21

/-

読み込み中…